Drug Discovery Alliances’ management has carefully identified and selected a portfolio of world class contract research and manufacturing companies to be formally and contractually represented by Drug Discovery Alliances. The companies in the Drug Discovery Alliances portfolio have a proven track record in assisting pharmaceutical clients with IND enabling programs to the point of licensing and development programs to commercial readiness. By working with our organization our clients can take advantage of a seamless and integrated approach to drug discovery and development with a portfolio of companies that have a proven track record of success in pharmaceutical research and development. Our client can realize quick access to a number of services by just making one phone call.
That need was the effective partnership building between outsourcing providers and outsourcing contractors in the United States. Her services have a provided her clients with not only a substantial, but sustained revenue stream.
Dr. Minor focuses her business model on the building of relationships and not the building of contracts. It is through this continued emphasis on successful relationships that she and her staff have been able to provide a large percentage of repeat business to her customers.
Process Research
Medicinal Chemistry
Handling of DEA controlled substances
Impurity and Metabolite Characterization
Sourcing of Reference Standards
Route Scouting
Free Screening, SFC separations under cGMP
Stability studies
Patent and Intellectual property challenges
Phase 1 to Commercial API Manufacturing
Sourcing of raw materials, API’s and intermediates, globally
In-Vitro ADME toxicology
Pre-formulation work, salt and polymorph screens
Final Dose Manufacturing including solid dose and IV, pre-IND to commercial